Aprepitant/Fosaprepitant Dimeglumine and Siltuximab Intravenous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Silvadene
- Aprepitant/Fosaprepitant Dimeglumine-Silvadene Topical
- Aprepitant/Fosaprepitant Dimeglumine-SilvaSorb
- Aprepitant/Fosaprepitant Dimeglumine-Silver
- Aprepitant/Fosaprepitant Dimeglumine-Silver Nitrate
- Aprepitant/Fosaprepitant Dimeglumine-Silver Nitrate Applicators
- Siltuximab Intravenous-Apresazide
- Siltuximab Intravenous-Apresoline
- Siltuximab Intravenous-Apresoline Injection
- Siltuximab Intravenous-Apri
- Siltuximab Intravenous-Apriso
- Siltuximab Intravenous-Aprizio Pak